P233 24-HR, 6-WEEK BACK PATCH – NEW EXTENDED HOURS


P233 24-HR, 6-WEEK BACK PATCH – NEW EXTENDED HOURS
Posted  September 3, 2021

START DATE09/17/2021
QUALIFICATIONSMen & Women Ages 18 to 70
TIME REQUIREMENT15 visits 9/17, 9/20, 9/22, 9/24, 9/27, 9/29, 10/1, 10/4, 10/6, 10/8; Challenge Phase : 10/25, 10/26, 10/27. 10/28, 10/29 (Monday - Friday)
COMPENSATION$250

NOTE: YOU MUST WEAR A FACE MASK/COVERING WHILE IN THE ECRL FACILITY.
* Children are not permitted in the ECRL facility unless they have a scheduled pediatric study appointment.
*Purses, back packs or other personal bags may not be brought into the lab at this time.

Study Hours:  7 A.M. TO 6:30 P.M.
Visits : 9/17, 9/20, 9/22, 9/24, 9/27, 9/29, 10/1, 10/4, 10/6, 10/8; Challenge Phase : 10/25, 10/26, 10/27. 10/28, 10/29 (Monday – Friday)

Inclusion Criteria:
1. Subject is male or female between 18 and 70 years of age;
2. Subject does not exhibit any skin diseases or abnormalities which might be confused with a skin reaction from the test material;
3. Subject agrees to avoid excessive sun exposure of the test sites and to refrain from visits to tanning salons during the course of this study;
4. Subject agrees to refrain from getting patches wet, scrubbing or washing the test area with soap, and applying powders, lotions or personal care products to the area during the course of the study;
5. Subject agrees not to introduce any new cosmetic or toiletry products during the study;
6. Subject is dependable and able to follow directions as outlined in the protocol;
7. Subject is willing to participate in all study evaluations;
8. Subject is in generally good health and has a current Panelist Profile Form and Medical History Form on file at CRL;
9. Subject has completed a HIPAA Authorization Form in conformance with 45 CFR Parts 160 and 164;
10. Subject understands and is willing to sign an Informed Consent Form in conformance with 21 CFR Part 50: “Protection of Human Subjects.”

Exclusion Criteria:
1. Female subject is pregnant, nursing, planning a pregnancy, or not using adequate birth control;
2. Subject has received treatment with sympathomimetics, antihistamines, vasoconstrictors, non-steroidal anti-inflammatory agents, and/or systemic or topical corticosteroids within one week prior to initiation of the study;
3. Subject has a history of acute or chronic dermatologic (including active eczema or psoriasis on the test sites), medical, and/or physical conditions which would preclude application of the test material and/or could influence the outcome of the study;
4. Subject is under treatment for a skin and/or systemic bacterial infection;
5. Subject has scheduled, or is planning to undergo, any medical or surgical procedures during the 6 week course of the study
6. Subject exhibits birthmarks, moles, vitiligo, keloids, or any dermal markings on the back that might interfere with grading;
7. Subject is an insulin-dependent diabetic;
8. Subject has a history of skin cancer or is currently undergoing treatment for active cancer of any type
9. Subject reports a history of allergies to tape adhesives;
10. Subject is currently taking certain medications which, in the opinion of the Principal Investigator, may interfere with the study;
11. Subject has known allergies to skin treatment products or cosmetics, toiletries, and/or topical drugs.




Sign up today!